Cart
sales@molnova.com
L-Sulforaphane
CAS No. 142825-10-3
L-Sulforaphane( (R)-Sulforaphane )
Catalog No. M21483 CAS No. 142825-10-3
(R)-Sulforaphane is a potent inducer of the Keap1/Nrf2/ARE pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 74 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 357 | In Stock |
|
| 50MG | 525 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-Sulforaphane
-
NoteResearch use only, not for human use.
-
Brief Description(R)-Sulforaphane is a potent inducer of the Keap1/Nrf2/ARE pathway.
-
Description(R)-Sulforaphane is a potent inducer of the Keap1/Nrf2/ARE pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms(R)-Sulforaphane
-
PathwayOthers
-
TargetOther Targets
-
RecptorKEAP1-Nrf2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142825-10-3
-
Formula Weight177.3
-
Molecular FormulaC6H11NOS2
-
Purity>98% (HPLC)
-
SolubilityDMSO:16mg/ml(90.24mM)
-
SMILESC[S@](CCCCN=C=S)=O
-
Chemical Name(R)-1-isothiocyanato-4-(methylsulfinyl)butane
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De Nicola GR et al. Novel gram-scale production of enantiopure R-sulforaphane from Tuscan black kale seeds. Molecules. 2014 May 27;19(6):6975-86.
molnova catalog
related products
-
Sodium dodecyl sulfa...
Sodium dodecyl sulfate(Sodium lauryl sulfate) is a pharmaceutical excipient that is biologically inactive and improves the stability, solubility and processability of pharmaceutical preparations.
-
1,2-Dihydrotanshinqu...
1,2 Dihydrotanshinquinone is active against both Trypanosoma brucei rhodesiense and Plasmodium falciparum.
-
Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.
